TransCode Therapeutics, Inc. (RNAZ) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for TransCode Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -0.14x | -1.40x | -1.25x | -321.59x | -2022.71x | -9318.08x |
| P/B Ratio | 0.46x | -11.66x | 14.10x | 1743.07x | 678.39x | -6408.18x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 6.29x | 2.56x | 1.28x | 1.70x | 8.97x | 2.05x |
| Quick Ratio | 6.29x | 2.56x | 1.28x | 1.70x | 8.97x | 2.05x |
| Leverage | ||||||
| Debt/Equity | 0.00x | -0.02x | 0.27x | 0.00x | 0.00x | -0.61x |
YoY = year-over-year change. Source: FMP..